Please enable Javascript to use all features and improve your user experience.
GfV 2023
Programme
Posters
People
Search
EN
All people
Prof. Dr. Christine Goffinet
Berlin / DE
Charité – Universitätsmedizin Berlin
Sort by Type
Date
Speaker
30/03/2023
09:15
–
09:30
12 Min.
3 Min.
Abstract Talk
O 082
Pharmacological inhibition of bromodomain and extra-terminal proteins induces NRF-2-mediated inhibition of SARS-CoV-2 replication and is subject to viral antagonism
Antiviral therapy and resistance, Host cell factors and modulation
Further involvements
28/03/2023
Poster
P 211
Characterization of extracellular vesicles from various body fluids that show broad antiviral activities
Host cell factors and modulation, Innate immunity
28/03/2023
Poster
P 040
Combining latency-reversing agents with type I IFNs accumulates HIV-1 Env on the cell surface and sensitizes for the elimination of HIV-reactivating cells through antibody-dependent cellular cytotoxicity
Antiviral therapy and resistance, Viral pathogenesis and persistence
28/03/2023
Poster
P 338
SARS-CoV-2 exposure facilitates LRA-mediated reactivation of HIV-1 in latently infected monocytes
Host cell factors and modulation, Viral pathogenesis and persistence
28/03/2023
Poster
P 119
MPOX virus infects human PBMCs in a type I interferon-sensitive manner
Emerging viruses and zoonosis, Host cell factors and modulation
28/03/2023
Poster
P 246
SARS-CoV-2 cell-to-cell transmission, as opposed to cell-free infection, evades from cell-intrinsic innate and humoral immunity
Innate immunity, SARS-CoV-2
28/03/2023
18:45
–
19:00
12 Min.
3 Min.
Abstract Talk
O 029
A novel role for ISG15 in restricting acute and persistent HIV-1 infection
Innate immunity, Viral pathogenesis and persistence
30/03/2023
09:15
–
09:30
12 Min.
3 Min.
Abstract Talk
O 082
Pharmacological inhibition of bromodomain and extra-terminal proteins induces NRF-2-mediated inhibition of SARS-CoV-2 replication and is subject to viral antagonism
Antiviral therapy and resistance, Host cell factors and modulation
31/03/2023
11:45
–
12:00
12 Min.
3 Min.
Abstract Talk
O 107
A novel, high dimensional model of latent HIV-1 infection and latency reversal cure strategies
Antiviral therapy and resistance, Viral pathogenesis and persistence
v1.21.0
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy